biofil chemicals & pharms
(BFC:Natl India)
biofil chemicals & pharms (BFC) Snapshot
|
Open
2.10
|
Previous Close
2.10
|
|
|
Day High
2.10
|
Day Low
2.10
|
|
|
52 Week High
07/23/12 - 4.43
|
52 Week Low
05/3/13 - 2.08
|
|
|
Market Cap
34.2M
|
Average Volume 10 Days
140.0
|
|
|
EPS TTM
0.09
|
Shares Outstanding
16.3M
|
|
|
EX-Date
01/1/96
|
P/E TM
22.8x
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
biofil chemicals & pharms (BFC) Related Businessweek News
No Related Businessweek News Foundbiofil chemicals & pharms (BFC) Details
Biofil Chemicals & Pharmaceuticals Ltd. engages in the production and sale of pharmaceutical products primarily in India. It offers pharmaceuticals, bulk drugs, and formulations. The company is based in Indore, India.
biofil chemicals & pharms (BFC) Key Developments
Biofil Chemicals & Pharmaceuticals Ltd. reported unaudited earnings results for the third quarter and nine months year ended December 31, 2012. For the quarter, the company reported total income from operations of INR 7.918 million compared to INR 3.655 million a year ago. Profit from operations before other income interest, finance costs and exceptional items was INR 0.492 million compared to INR 0.458 million a year ago. Profit from ordinary activities before income tax was INR 0.352 million compared to INR 0.347 million a year ago. Net profit was INR 0.352 million compared to INR 0.347 million a year ago. Basic and diluted earnings per share was INR 0.0022 compared to INR 0.0021 a year ago. For the nine months, the company reported total income from operations of INR 27.162 million compared to INR 14.00 million a year ago. Profit from operations before other income interest, finance costs and exceptional items was INR 1.596 million compared to INR 1.90 million a year ago. Profit from ordinary activities before income tax was INR 1.206 million compared to INR 1.384 million a year ago. Profit from ordinary activities after tax was INR 0.854 million compared to INR 1.037 million a year ago. Net profit was INR 1.206 million compared to INR 1.384 million a year ago. Basic and diluted earnings per share were INR 0.0074 compared to INR 0.0085 a year ago.
Biofil Chemicals & Pharmaceuticals Ltd., Board Meeting, Feb 12, 2013. Agenda: To consider quarterly results.
Biofil Chemicals & Pharmaceuticals Ltd. reported unaudited earnings results for the second quarter and half year ended September 30, 2012. For the quarter, the company reported total income from operations of INR 7.063 million compared to INR 2.913 million a year ago. Profit from operations before other income interest and exceptional items was INR 0.466 million compared to INR 0.970 million a year ago. Profit from ordinary activities before income tax was INR 0.341 million compared to INR 0.695 million a year ago. Profit from ordinary activities after tax was INR 0.341 million compared to INR 0.695 million a year ago. Net profit was INR 0.341 million compared to INR 0.695 million a year ago. Basic and diluted earnings per share was INR 0.0021 compared to INR 0.0043 a year ago. For the half year, the company reported total income from operations of INR 19.244 million compared to INR 10.345 million a year ago. Profit from operations before other income interest and exceptional items was INR 1.104 million compared to INR 1.442 million a year ago. Profit from ordinary activities before income tax was INR 0.854 million compared to INR 1.037 million a year ago. Profit from ordinary activities after tax was INR 0.854 million compared to INR 1.037 million a year ago. Net profit was INR 0.854 million compared to INR 1.037 million a year ago. Basic and diluted earnings per share were INR 0.0052 compared to INR 0.0064 a year ago.

| Recently Viewed | |||
| BFC:IN | 2.10 INR | 0.00 | |
| Company | Last | Change | |
| No competitor information is available for BFC. | |||
| View Industry Companies | |||
Industry Analysis
BFC
Industry Average
| Valuation | BFC | Industry Range |
| Price/Earnings | -- | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | -- | Not Meaningful |
| Price/Cash Flow | 12.6x |
|
| TEV/Sales | 0.2x |
|
Post a JobJobs
- Chicago, IL | DunnhumbyusaPosted: Jun 18
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
Sponsored Financial Commentaries
Sponsored Links
To contact BIOFIL CHEMICALS & PHARMS, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








